Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1 AND Prognosis
16 results:

  • 1. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.
    Müller D; Győrffy B
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188722. PubMed ID: 35307512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer.
    Dong D; Zhang R; Shao J; Zhang A; Wang Y; Zhou Y; Li Y
    Clin Epigenetics; 2021 Dec; 13(1):225. PubMed ID: 34922605
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A combination of methylation and protein markers is capable of detecting gastric cancer detection by combined markers.
    Xu J; Song J; Wang T; Zhu W; Zuo L; Wu J; Guo J; Yang X
    Epigenomics; 2021 Oct; 13(19):1557-1570. PubMed ID: 34632818
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. msept9 Can Monitor the Response and Predict the prognosis of Stage IV colorectal cancer Patients with Liver Metastasis Undergoing Potentially Curative Surgery.
    Liu W; Hu P; Liu J; Chen L
    J Surg Res; 2021 Nov; 267():485-494. PubMed ID: 34246842
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. sept9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells.
    Jiang Y; Liu L; Xiang Q; He X; Wang Y; Zhou D; Zou C; Chen Q; Peng M; He J; Jiang X; Xiang T; Yang Y
    Clin Epigenetics; 2020 Mar; 12(1):41. PubMed ID: 32138771
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
    Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
    World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Roles of Methylated DNA Biomarkers in Patients with colorectal cancer.
    Ma Z; Williams M; Cheng YY; Leung WK
    Dis Markers; 2019; 2019():2673543. PubMed ID: 30944663
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for colorectal cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The blood msept9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer.
    Song L; Guo S; Wang J; Peng X; Jia J; Gong Y; Yang B; Xiao W; Dong C; Liu H; Li Y
    Biomark Med; 2018 Sep; 12(9):961-973. PubMed ID: 30043648
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
    Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A systematic review of the performance of the sept9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.
    Song L; Yu H; Jia J; Li Y
    Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DNA methylation based biomarkers in colorectal cancer: A systematic review.
    Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
    Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.
    Rasmussen SL; Krarup HB; Sunesen KG; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    Colorectal Dis; 2016 Jun; 18(6):549-61. PubMed ID: 26998585
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Blood-based testing for colorectal cancer screening.
    Heichman KA
    Mol Diagn Ther; 2014 Apr; 18(2):127-35. PubMed ID: 24307563
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.
    Gyparaki MT; Basdra EK; Papavassiliou AG
    J Mol Med (Berl); 2013 Nov; 91(11):1249-56. PubMed ID: 24057814
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.